Lucie Heinzerling

4PUBLICATIONS
21CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Jun 12, 2026
Extracorporeal photopheresis versus systemic immunosuppression for treatment of immune-related adverse events: clinical outcomes from the prospective two-arm PRIA study.

|Sep 24, 2025
Infliximab is a safe and effective treatment in steroid-refractory immune-related hepatitis.

Kim Nikola Oliva, Lisa Arnold, Lucie Heinzerling

|Feb 04, 2025
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.

Thomas Eigentler, Ioannis Thomas, Igor Samoylenko

|Apr 07, 2023
Brain metastasis and survival outcomes after first-line therapy in metastatic melanoma: a multicenter DeCOG study on 1704 patients from the prospective skin cancer registry ADOREG.

Cindy Franklin, Peter Mohr, Leonie Bluhm

Pageof 1

Frequent Collaborators

2 joint publications

Patrick Terheyden

2 joint publications

Bastian Schilling

2 joint publications

Lisa Wein

1 joint publications

Cindy Franklin